Association of functional GITR gene polymorphisms related to expression of glucocorticoid-induced tumour necrosis factor-receptor (GITR) molecules with prognosis of autoimmune thyroid disease

Clinical and Experimental Immunology

Volumn 165, Issue 2, 2011, Pages 141-147

  Tomizawa, R ^a   Watanabe, M ^a   Inoue, N ^a   Takemura, K ^a   Hidaka, Y ^a   Akamizu, T ^b   Hayakawa, K ^a   Iwatani, Y ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

GITR; Graves' disease; Hashimoto's disease; Polymorphism; Regulatory T cells

Indexed keywords

ANTITHYROID AGENT; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; LEVOTHYROXINE; PROPYLTHIOURACIL; THIAMAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ASSOCIATION; GENOTYPE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; RESTRICTION MAPPING; SCHOOL CHILD; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BASE SEQUENCE; FEMALE; FLOW CYTOMETRY; GENE FREQUENCY; GENOTYPE; GLUCOCORTICOID-INDUCED TNFR-RELATED PROTEIN; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RESTRICTION MAPPING; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 79960072082     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04414.x     Document Type: Article

References (28)

1. Nocentini G, Giunchi L, Ronchetti S etal. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc Natl Acad Sci USA 1997; 94:6216-21.
2. + T cell activation and experimental autoimmune encephalomyelitis. J Immunol 2004; 172:4686-90.
3. - regulatory T cells. J Immunol 2006; 176:4748-56.
4. + natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212:8-27.
5. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002; 3:135-42.
6. Li Z, Mahesh SP, Kim BJ, Buggage RR, Nussenblatt RB. Expression of glucocorticoid induced TNF receptor family related protein (GITR) on peripheral T cells from normal human donors and patients with non-infectious uveitis. J Autoimmun 2003; 21:83-92.
7. Nocentini G, Riccardi C. GITR: a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 2005; 35:1016-22.
8. + T cells. J Immunol 2004; 173:5008-20.
9. Ji HB, Liao G, Faubion WA etal. Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression. J Immunol 2004; 172:5823-7.
10. Esparza EM, Arch RH. Glucocorticoid-induced TNF receptor, a costimulatory receptor on naive and activated T cells, uses TNF receptor-associated factor 2 in a novel fashion as an inhibitor of NF-κB activation. J Immunol 2005; 174:7875-82.
11. + T cells. Biochem Biophys Res Commun 2008; 369:1134-8.
12. + regulatory T cells mediated by GITR molecules. Immunol Lett 2008; 121:97-104.
13. +high regulatory T cell function. J Immunol 2002; 169:6210-17.
14. + regulatory T cells in the induction and maintenance of transplantation tolerance. Transpl Immunol 2007; 17:120-9.
15. + T cells. Immunology 2006; 119:479-87.
16. + regulatory T cells. J Immunol 2003; 171:708-16.
17. + T-cell-mediated tolerance to experimental autoimmune thyroiditis by glucocorticoid-induced tumor necrosis factor receptor monoclonal antibody. J Autoimmun 2006; 26:24-31.
18. Marazuela M, Garcia-Lopez MA, Figueroa-Vega N etal. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 2006; 91:3639-46.
19. Hayashi F, Watanabe M, Nanba T, Inoue N, Akamizu T, Iwatani Y. Association of the -31C/T functional polymorphism in the interleukin-1β gene with the intractability of Graves' disease and the proportion of T helper type 17 cells. Clin Exp Immunol 2009; 158:281-6.
20. Ito C, Watanabe M, Okuda N, Watanabe C, Iwatani Y. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-γ gene. Endocr J 2006; 53:473-8.
21. Nanba T, Watanabe M, Akamizu T, Iwatani Y. The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin Chem 2008; 54:621-3.
22. Yamada H, Watanabe M, Nanba T, Akamizu T, Iwatani Y. The +869T/C polymorphism in the transforming growth factor-β1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin Exp Immunol 2008; 151:379-82.
23. Inoue N, Watanabe M, Morita M etal. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin Exp Immunol 2010; 162:402-6.
24. + cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid 2002; 12:801-8.
25. Santoh T, Watanabe M, Kuroda S, Ueda D, Iwatani Y. Ratio of serum IgG3 to total IgG concentration and goiter size are independent factors in intractability of Graves' disease. Endocr J 2007; 54:887-94.
26. Motta AC, Vissers JL, Gras R, Van Esch BC, Van Oosterhout AJ, Nawijn MC. GITR signaling potentiates airway hyperresponsiveness by enhancing Th2 cell activity in a mouse model of asthma. Respir Res 2009; 10:93-100.
27. Nanba T, Watanabe M, Inoue N, Iwatani Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid 2009; 19:495-501.
28. Pan D, Shin YH, Gopalakrishnan G, Hennessey J, De Groot LJ. Regulatory T cells in Graves' disease. Clin Endocrinol (Oxf) 2009; 71:587-93.